Skip to content
Recall Observatory FDA recall evidence

Drug product

BSS Plus/Lidocaine Opth 1% (1ML syringe) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

D-0195-2023

December 22, 2022

Class II

Product summary

Firm
Pharmacy Innovations
Event
Event 91332
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0195-2023

Official wording

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Code information: t20221004@47

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility